Healx
UK - CambridgeBiotechnology
Focus: Healx is an AI-driven drug discovery company founded in 2005 and headquartered in Cambridge, UK, focused on rare diseases and neurology with a pipeline of 11 programs across phases 1–3. As a publicly-listed biotech, the company leverages artificial intelligence to accelerate identification and development of novel therapeutics for ultra-rare conditions.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Healx?
AI assessmentHealx offers compelling late-stage pipeline upside and rare-disease credibility, but constrained hiring and opaque financials carry material career-stability risk; best suited for specialists willing to bet on 2–3 year Phase 3 catalysts.
Why Work Here
- Access to a mature, Phase 3-stage pipeline with two programs actively in late-stage development (Gaboxadol for Angelman Syndrome and OV101 for Angelman Syndrome), offering near-term commercialization visibility.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
OV101
Angelman SyndromeClinical Trials (1)
NCT03109756Single Dose Pharmacokinetic (PK) Study
Phase 1Help build intelligence for Healx
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.